August 17, 2017 2:27 PM ET


Company Overview of Colorcon, Inc.

Company Overview

Colorcon, Inc. provides a range of pharmaceutical film coatings and pharmaceutical formulation development assistance. The company provides film coatings, excipients, polymers for controlled release, nutritional coatings, and printing inks, as well as food colorants, glazes and polishes, and confectionary inks. It serves pharmaceutical and nutritional supplement customers. The company was founded in 1961 and is based in Harleysville, Pennsylvania with locations in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. Colorcon, Inc. operates as a subsidiary of BPSI Holdings Inc.

275 Ruth Road

Harleysville, PA 19438

United States

Founded in 1961





Key Executives for Colorcon, Inc.

Chief Executive Officer
Global Communication Director
General Manager for Formulation Technologies
Compensation as of Fiscal Year 2017.

Colorcon, Inc. Key Developments

Colorcon, Inc. Signs Co-Operation Agreement with BASF SE

Colorcon, Inc. and BASF SE have signed an agreement to strengthen their co-operation in the area of pharmaceutical film coatings. As part of this agreement, BASF will sell its Kollicoat IR Coating Systems product line to Colorcon; including the current customer business, inventory and relevant know-how. The addition of the Kollicoat IR Coating Systems complements Colorcon's existing film coating product line and position as a leading innovator of fully formulated film coating systems and provides Kollicoat IR Coating Systems customers with a wide range of film coating options. Final closure of the transaction is subject to review of the Brazilian competition authorities. By acquiring the Kollicoat IR Coating Systems, Colorcon further strengthens its existing activities with PVA-based pigmented, ready-to-use film coatings, for use on immediate release forms of pharmaceuticals and dietary supplements.

Colorcon, Inc. Delivers Savings, Speed and Flexibility for Pharmaceutical Film Coating with Opadry® Qx

Colorcon Inc. announced an innovative breakthrough for pharmaceutical tablet coating, with the launch of Opadry® QX, quick and fleXible film coating. This revolutionary advance greatly reduces production and preparation times, ensuring coating process efficiency and cost savings in all types of equipment, from traditional pans to continuous coating equipment. The system can be applied over a broad range of process conditions and always results in a premium quality finish for tablets, even those containing temperature-sensitive active ingredients.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Colorcon, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at